Boxes of GLP-1 medications
The FDA is requiring all GLP-1 medications, including Novo Nordisk’s Ozempic and Wegovy to carry the risk on warning labels. Photograph: Hollie Adams/Reuters
The FDA is requiring all GLP-1 medications, including Novo Nordisk’s Ozempic and Wegovy to carry the risk on warning labels. Photograph: Hollie Adams/Reuters
FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications

The federal agency is requiring all GLP-1s to include information about the potential risk on warning labels